Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn

Collaborative Programmes and Centres



BREAST-PREDICT is the first, Irish Cancer Society-funded Collaborative Cancer Research Centre in Breast Cancer, and brings together researchers UCD, TCD, RCSI, DCU, NUIG and UCC, and the clinical trials group, ICORG. Its mission is to improve the understanding of how breast cancer spreads and becomes resistant to treatment, and develop better therapies.


APO-DECIDE is a FP7 funded collaborative project using systems medicine to deliver personalised medicine for colorectal cancer.


ANGIOPREDICT is a FP7 funded collaborative research project working towards personalised medicine for patients with metastatic colorectal cancer.


MEL-PLEX is funded by the European Commission's Horizon 2020 Marie S. Curie Actions Programme to coordinate a research and training network, MEL-PLEX addresses current needs in academia and the private sector for researchers that have been interdisciplinarily trained, that can navigate confidently between academic, clinical and private sector research environments, and that have developed an innovative and creative mindset to progress research findings towards applications. In collaboration with Technical University Dresden, University of Luxembourg, University of Berne, University of Leuven, University of Heidelberg, University College Dublin, the Danish Cancer Research Center,Oncomark Ltd, Optimata Ltd, ProtATonce Ltd, Merrimack Pharmaceutical Ltd, Apogenix Ltd, Novartis Ltd., Massachusetts General Hospital, Galderma Pharma Ltd, and the Haadssah Hebrew University Medical Center, the scientific objective of MEL-PLEX is to employ molecular, mechanistic and mathematical systems-level disease understanding in order to improve the prognosis and treatment of primary and metastatic melanoma.

MCTI - Molecular Therapeutic for Cancer Ireland

The MTCI is a Science Foundation Ireland (SFI)-funded Strategic Research Cluster which aims to discover and develop new anti-cancer drugs. Partners include DCU, UCD, TCD, and ICORG, funded by SFI under the Strategic Research Cluster Scheme.


MErCuRIC is a FP7-funded multicentre phase Ib/II clinical trial which will assess a novel therapeutic strategy (combined treatment of a MEK inhibitor MEK-162 with a MET inhibitor PF-02341066) to combat metastasis, improve survival and change current clinical practice for colorectal cancer (CRC) patients with KRAS mutant (MT) and KRAS wild-type (WT) (with aberrant c-MET) tumours. The consortium will go beyond the current state-of-the-art by (i) employing a novel treatment strategy targeting the biology of the disease and by (ii) using next-generation sequencing (NGS) and ‘xenopatients’ to identify CRC patient subgroups who will maximally benefit from this novel treatment strategy.

Regenerative medicine, biomaterials and drug delivery

AMBER - Advanced Materials and BioEngineering Research

Science Foundation Ireland (SFI)-funded AMBER Centre, provides a partnership between leading researchers in material science and industry, bringing together leading international research centres in bioengineering and nanotechnology, the Trinity Centre for Bioengineering (TCBE) and Centre for Research on Adaptive Nanostructures and Nanodevices (CRANN) in addition to the Tissue Engineering Research Group based at RCSI, as well as researchers in materials chemistry from UCC. The aim of the centre is to deliver internationally leading materials research that will be industrially and clinically informed with outputs including new discoveries and devices. AMBER has an exceptionally strong emphasis on linking industry to research programmes and its goal is to become an internationally recognised centre of excellence for materials - based in Ireland.

AMCARE - Advanced Materials for Cardiac Regeneration 

AMCARE is a translational research program to develop advanced multimodal regenerative therapies using cardiopoeitic stem cells and smart biomaterials that effectively treat damage caused by acute myocardial infarction (MI). This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration.

CÚRAM - Centre for Research in Medical Devices - Galway

SFI Research Centre CÚRAM, is to radically improve health outcomes for patients by developing innovative implantable medical devices, to respond to the body's environment and to deliver therapeutic agents, such as drugs, exactly where needed. CÚRAM's outputs will particularly benefit patients with chronic diseases such as heart disease, diabetes and musculoskeletal diseases. Devices will be developed with strong clinical collaborations, with industry partners and hospital groups, to enable rapid translation to the clinic.

IDDN Irish Drug Delivery Research Network

The IDDN cluster includes RCSI with partner TCD, UCD, UCC, funded by SFI under the Strategic Research Cluster Scheme and provides research solutions for academia and industry in the field of drug delivery.


VISICORT is a FP7-funded multi-disciplinary project with expertise in basic immunology, bio-sampling, systems biology/immune profiling, bioinformatics, clinical tissue transplantation and cell therapy. Clinical data and bio-specimens from over 700 CT recipients at 5 leading transplant centres will be centrally collated and distributed to cutting-edge university- and SME-based laboratories for multi-platform profiling and integrated bioinformatics analyses.

Neuroscience and mental disorders


The EpimiRNA Consortium, involving 16 partners from 8 European countries, the USA and Brazil is funded from the European Union's Framework Programme 7 to investigate molecular mechanisms, diagnostics and treatments for epilepsy.

CSND (Centre for the Study of Neurological Disorders)

CSND is the only centre in Ireland devoted to the study of acute and chronic neurological disorders. The mission of the CSND is to advance fundamental knowledge of the basis of neurological disorders by conducting cutting edge research and by providing training to the next generation of scientists.

CSM (Centre for Systems Medicine)

The mission of the CSM is to undertake translational, multidisciplinary research that identifies proteins and genes implicated in human disease and utilises systems biology and mathematical approaches in order to develop new prognostic tools for the treatment of cancer, neurological disorders and diabetes, and to develop more targeted therapies for patients.

Respiratory diseases

EU COST ACTION: BM1003  -  Microbial determinants in cystic fibrosis. 

Population health sciences and primary care

The HRB Centre for Primary Care Research 

A multidisciplinary collaboration between RCSI (lead), TCD and Queen's University Belfast. The HRB Centre for Primary Care Research is researching the quality of care across the primary/secondary care interface in vulnerable patient groups and developing information and communication technology (ICT) interventions to improve patient care. The HRB Centre has developed a critical mass of young, motivated academics from a multi-disciplinary background, employing over 45 people in a five-year period more...


The CHRAIC programme 

A partnership including TCD, NUIG, six African countries and one non-governmental organisation.


COST-Africa is a research project funded under a European Union (EU) FP7 grant. It will design, implement and evaluate a scalable Clinical Officer (CO) surgical training programme in Malawi and Zambia. The result will be proof-of-concept that surgery can be delivered cost-effectively, safely and bring important health benefits to patients attending district hospitals in these two countries.

Cardiovascular disease

Biomedical Diagnostics Institute

The Biomedical Diagnostics Institute (BDI) is a multidisciplinary research institute focused on the development of next generation point-of-care biomedical diagnostics devices. A Science Foundation Ireland (SFI) ... read more...

Perinatal/neonatal health

Perinatal Ireland

Perinatal Ireland is a large-scale, multi-center clinical research consortium funded by the HRB and led by RCSI, which comprises eight leading Irish fetal medicine centres, whose mission is to improve perinatal outcomes for mothers and babies using advanced ultrasound technologies focusing on cutting-edge research relating to all aspects of improving women's and children's health ... read more... 


INFANT is Ireland's first perinatal research centre. Funded by Science Foundation Ireland and based at Cork University Maternity Hospital, INFANT is developing solutions to address the unmet worldwide clinical need for effective screening tests for the most common complications of pregnancy and the most significant problems for newborn babies.


National Biophotonics Imaging Platform

The National Biophotonics Imaging Platform (NBIP) Ireland was established in 2007 under HEA PRTLI Cycle 4. The platform consists of a consortium of imaging and biophotonics laboratories from across the Universities and Institutes of Technology ... read more...

Career Enhancement Mobility Programme

The Career Enhancement Mobility Programme (CEMP) is a postdoctoral fellowship programme co-funded by the EU FP7 MarieCurie Co-fund Scheme, the Irish Higher Education Authority Programme for Third Level Institutions Cycle 4 and ... read more...


Euro-BioImaging is a pan-European research infrastructure project which is part of the ESFRI process. The aim of Euro-BioImaging is to provide access to imaging technologies across the full scale of biological and medical applications ... read more...